Episode 3 – Investing in Biotech Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Chris Behrenbruch from Telix Pharmaceuticals and David Blake. Read more articles Previous PostEpisode 2 – Accessing US markets – Nasdaq and FDA approval Next PostEpisode 4 – Investing in Biotech